L. Matzen et al., AMPA RECEPTOR AGONISTS - SYNTHESIS, PROTOLYTIC PROPERTIES, AND PHARMACOLOGY OF 3-ISOTHIAZOLOL BIOISOSTERES OF GLUTAMIC-ACID, Journal of medicinal chemistry, 40(4), 1997, pp. 520-527
A number of 3-isothiazolol bioisosteres of glutamic acid (1) and analo
gs of the AMPA receptor agonist, amino-3-(3-hydroxy-5-methylisoxazol-4
-yl)propionic acid(AMPA,2a), including ino-3-(3-hydroxy-5-methylisothi
azol-4-yl)propionic acid (thio-AMPA, 2b), were synthesized. Comparativ
e in vitro pharmacological studies on this series of 3-isothiazolol an
d the corresponding 3-isoxazolol amino acids were performed using a se
ries of receptor binding assays (IC50 values) and the electrophysiolog
ical rat cortical slice model (EC(50) values). Whereas 2a (IC50 = 0.04
+/- 0.005 mu M, EC(50) = 3.5 +/- 0.2 mu M) is markedly more potent th
an the tert-butyl analog ATPA (3a) (IC50 = 2.1 +/- 0.16 mu M, EC(50) =
34 +/- 2.4 mu M) in [H-3]AMPA binding and electrophysiological studie
s, 2b (IC50 = 1.8 +/- 0.13 mu M, EC(50) = 15.0 +/- 2.4 mu M) was appro
ximately equipotent with thio-ATPA (3b) (IC50 = 0.63 +/- 0.07 mu M, EC
(50) = 14 +/- 1.3 mu M) (RS)-2-Amino-3-(3-hydroxyisoxazol-5-yl)propion
ic acid (HIBO, 4a) was approximately equipotent with its thio analog 4
b, whereas 4-Br-HIBO (5a) (IC50 = 0.65 +/- 0.12 mu M, EC(50) = 22 +/-
0.6 mu M) turned out to be much more potent than the corresponding 3-i
sothiazolol 5b (IC50 = 17 +/- 2.2 mu M, EC(50) = 500 +/- 23 mu M). 2b
(ED(50) = 130 mu mol/kg) was more patent than 2a (220 mu mol/kg) as a
convulsant after subcutaneous administration in mice. The protolytic p
roperties of 2a,b-4a,b were determined using C-13 NMR spectroscopy. Fo
r each pair of compounds, the a-amino acid groups showed similar proto
lytic properties, whereas the 3-isoxazolol moieties typically showed p
K(a) values 2 units lower than those of the 3-isothiazolols. According
ly, calculations of ionic species distributions revealed pronounced di
fferences between 3-isoxazolol and 3-isothiazolol amino acids. No simp
le correlation between activity as AMPA agonists in vitro and pK(a) va
lues of these compounds was apparent. On the other hand, the relative
potencies of AMPA (2a) and thio-AMPA (2b) in vitro and in vivo may ref
lect that these compounds predominantly penetrate the blood-brain barr
ier as net uncharged diprotonated ionic species.